Significant improvement of right ventricular function by imatinib mesylate in scleroderma-associated pulmonary arterial hypertension

Clin Res Cardiol. 2009 Apr;98(4):265-7. doi: 10.1007/s00392-009-0752-3. Epub 2009 Feb 13.

Authors

Henrik ten Freyhaus¹, Daniel Dumitrescu, Henning Bovenschulte, Erland Erdmann, Stephan Rosenkranz

Affiliation

¹ Klinik III für Innere Medizin, Universität zu Köln, Köln, Germany.

PMID: 19219392
DOI: 10.1007/s00392-009-0752-3

No abstract available

Publication types

Case Reports

MeSH terms

Animals
Benzamides
Female
Humans
Hypertension, Pulmonary / drug therapy*
Hypertension, Pulmonary / etiology
Imatinib Mesylate
Middle Aged
Piperazines / pharmacology
Piperazines / therapeutic use*
Protein Kinase Inhibitors / pharmacology
Protein Kinase Inhibitors / therapeutic use
Pyrimidines / pharmacology
Pyrimidines / therapeutic use*
Scleroderma, Systemic / complications*
Treatment Outcome
Ventricular Dysfunction, Right / drug therapy
Ventricular Dysfunction, Right / etiology

Substances

Benzamides
Piperazines
Protein Kinase Inhibitors
Pyrimidines
Imatinib Mesylate